Extended-Release Calcifediol: A Data Journey From Phase 3 Studies to Real-World Evidence Highlights the Importance of Early Treatment of Secondary Hyperparathyroidism Nov 2, 2023
ASN Kidney Week 2023 Poster Presentation - Control of Secondary Hyperparathyroidism with Extended-release Calcifediol is Associated with Slower CKD Progression Nov 2, 2023
OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases May 9, 2022
ASN Kidney Week 2021 Oral abstract presentation- Initial Evaluation of High-Dose Extended-Release Calcifediol (ERC) in Patients with Stage 5 CKD on Hemodialysis (HD) Nov 5, 2021
Pituitary Society Presentation - Update on Somatrogon Development for the Treatment of Growth Hormone Deficiency in Pediatric and Adult Subjects Oct 28, 2020
Replay of the Evercore ISI COVID Dx Webinar with OPKO and BioReference Senior Leadership May 27, 2020
